News

Today at HLTH, panelists discussed how digital is changing the medication delivery space and who will pay for the services. 

The investment will support further growth in key markets.

The market is forecast to reach $9.13 billion (€7.84 billion) by 2026.

The partnership will initially be used to distribute PathAI’s research-use-only algorithm focusing on immuno-oncology.

Garmin’s new apps allow people using the Dexcom G6 CGM to see glucose levels and trends on their smartwatch.

IntelliSite is designed to streamline workflows, enhance diagnostic confidence, facilitate collaboration, integrate AI and increase the efficiency of pathology labs.

There is much more we can do to help people access the care they need and one benefit of the past year and a half has been a scale-up of digital tools, says Dr Harriet Bradley, UK medical director of Livi.

Also, US-based Pearl has received regulatory approvals to market its AI diagnostic tool for dental radiology in Australia and New Zealand.

The new tool will offer 10-minute lessons on CBT and provide mindfulness techniques. 

Propeller vet Chris Hogg writes on the go-to-market strategies for digital health companies.